|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
|
|---|---|---|
| Revenues | ||
| Cost of revenues | ||
| Gross profit | ||
| Operating expenses: | ||
| Selling and marketing | ||
| General and administrative | ||
| Impairment of intangible asset | ||
| Research and development | ||
| Total operating expenses | ||
| (Loss) income from operations | ||
| Other income (expense): | ||
| Financial (expense) income, net | ||
| Gain on acquisition of a subsidiary | ||
| Gain on fair value change of derivative liability | ||
| Other (expense) income, net | ||
| Total other (expenses) income, net | ||
| (Loss) income before income taxes | ||
| Income tax benefit (expense) | ||
| Net (loss) income | ||
| Less: net loss (income) attributable to non-controlling interests | ||
| Net Income Loss | ||
| Other comprehensive loss | ||
| Foreign currency translation adjustments | ||
| Comprehensive (loss) income | ||
| Less: Comprehensive loss (income) attributable to non-controlling interests | ||
| Comprehensive (loss) income attributable to shareholders | ||
| Net (loss) earnings per share | ||
| Basic (in dollars per share) | ||
| Diluted (in dollars per share) | ||
| Weighted average number of shares outstanding | ||
| Basic (in shares) | ||
| Diluted (in shares) |
Loading...
